Modeling of interactions between xenobiotics and cytochrome P450 (CYP) enzymes

H Raunio, M Kuusisto, RO Juvonen… - Frontiers in …, 2015 - frontiersin.org
The adverse effects to humans and environment of only few chemicals are well known.
Absorption, distribution, metabolism, and excretion (ADME) are the steps of pharmaco …

[HTML][HTML] Biotransformation in vitro: An essential consideration in the quantitative in vitro-to-in vivo extrapolation (QIVIVE) of toxicity data

I Wilk-Zasadna, C Bernasconi, O Pelkonen, S Coecke - Toxicology, 2015 - Elsevier
Early consideration of the multiplicity of factors that govern the biological fate of foreign
compounds in living systems is a necessary prerequisite for the quantitative in vitro–in vivo …

Understanding the metabolism of proteolysis targeting chimeras (PROTACs): the next step toward pharmaceutical applications

L Goracci, J Desantis, A Valeri… - Journal of Medicinal …, 2020 - ACS Publications
Hetero-bifunctional PROteolysis TArgeting Chimeras (PROTACs) represent a new emerging
class of small molecules designed to induce polyubiquitylation and proteasomal-dependent …

XenoSite: accurately predicting CYP-mediated sites of metabolism with neural networks

J Zaretzki, M Matlock… - Journal of chemical …, 2013 - ACS Publications
Understanding how xenobiotic molecules are metabolized is important because it influences
the safety, efficacy, and dose of medicines and how they can be modified to improve these …

Modeling epoxidation of drug-like molecules with a deep machine learning network

TB Hughes, GP Miller, SJ Swamidass - ACS central science, 2015 - ACS Publications
Drug toxicity is frequently caused by electrophilic reactive metabolites that covalently bind to
proteins. Epoxides comprise a large class of three-membered cyclic ethers. These …

Modeling reactivity to biological macromolecules with a deep multitask network

TB Hughes, NL Dang, GP Miller… - ACS central …, 2016 - ACS Publications
Most small-molecule drug candidates fail before entering the market, frequently because of
unexpected toxicity. Often, toxicity is detected only late in drug development, because many …

Lipostar, a comprehensive platform-neutral cheminformatics tool for lipidomics

L Goracci, S Tortorella, P Tiberi, RM Pellegrino… - Analytical …, 2017 - ACS Publications
To date, the main limitations for LC-MS-based untargeted lipidomics reside in the lack of
adequate computational and cheminformatics tools that are able to support the analysis of …

Model-based estimates of the effects of efavirenz on bedaquiline pharmacokinetics and suggested dose adjustments for patients coinfected with HIV and tuberculosis

EM Svensson, F Aweeka, JG Park… - Antimicrobial agents …, 2013 - Am Soc Microbiol
Safe, effective concomitant treatment regimens for tuberculosis (TB) and HIV infection are
urgently needed. Bedaquiline (BDQ) is a promising new anti-TB drug, and efavirenz (EFV) is …

Deep learning to predict the formation of quinone species in drug metabolism

TB Hughes, SJ Swamidass - Chemical research in toxicology, 2017 - ACS Publications
Many adverse drug reactions are thought to be caused by electrophilically reactive drug
metabolites that conjugate to nucleophilic sites within DNA and proteins, causing cancer or …

Structure–metabolism relationships in human-AOX: Chemical insights from a large database of aza-aromatic and amide compounds

S Lepri, M Ceccarelli, N Milani… - Proceedings of the …, 2017 - National Acad Sciences
Aldehyde oxidase (AOX) is a metabolic enzyme catalyzing the oxidation of aldehyde and
aza-aromatic compounds and the hydrolysis of amides, moieties frequently shared by the …